Henry E. Pelish - 31 Jan 2025 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role
Chief Scientific Officer
Signature
/s/ Nathan N. McConarty, attorney-in-fact
Issuer symbol
NUVL
Transactions as of
31 Jan 2025
Net transactions value
+$2,714
Form type
4
Filing time
04 Feb 2025, 16:46:01 UTC
Previous filing
08 Jan 2025
Next filing
10 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVL Class A Common Stock Options Exercise $2,714 +3,120 +5.2% $0.8700 63,101 31 Jan 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -3,120 -61% $0.000000 2,007 31 Jan 2025 Class A Common Stock 3,120 $0.8700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option are fully vested.